Please provide a SOAP note for a patient with left ear pain without infection who is taking apixaban (Eliquis) and aspirin.

SOAP Note: Left Ear Pain Without Infection (Patient on Eliquis and Aspirin)

Subjective

• Chief Complaint: Left ear pain
• History of Present Illness: Document onset, duration, severity, quality of pain, aggravating/relieving factors, associated symptoms (itching, fullness, hearing loss, discharge, fever)
• Key Questions to Ask:
  • Recent water exposure or swimming?
  • Trauma to ear canal (cotton swabs, hearing aids, earbuds)?
  • Pain with tragus/pinna manipulation?
  • Drainage or discharge?
  • Fever or systemic symptoms?
• Medications: Apixaban (Eliquis) - dose and indication; Aspirin - dose
• Past Medical History: Atrial fibrillation (likely indication for anticoagulation), cardiovascular disease, diabetes, immunocompromised state, prior radiation therapy

Objective

• Vital Signs: Temperature, blood pressure, heart rate
• Physical Examination:
  • Tragal tenderness test: Push on tragus and pull on pinna - positive finding suggests otitis externa
  • Otoscopic examination: Assess for ear canal edema, erythema, debris, discharge; evaluate tympanic membrane integrity and mobility
  • Pneumatic otoscopy (if possible): Normal mobility suggests otitis externa vs. limited mobility suggests acute otitis media
  • Periauricular examination: Check for cellulitis, lymphadenopathy
  • Cranial nerve examination: If severe or concerning for extension

Assessment

For ear pain WITHOUT infection (as stated in question), the differential diagnosis includes:

1. Mechanical/Traumatic Causes: Cerumen impaction, foreign body, trauma from cleaning
2. Dermatologic Conditions: Eczema, seborrhea, psoriasis of ear canal
3. Temporomandibular Joint (TMJ) Dysfunction: Referred pain
4. Eustachian Tube Dysfunction: Pressure-related pain
5. Referred Pain: Dental pathology, pharyngitis, cervical spine issues

Critical Consideration - Anticoagulation Status: This patient is on DUAL antiplatelet/anticoagulant therapy (apixaban + aspirin), which significantly increases bleeding risk 1, 2. Recent research demonstrates that combining apixaban with aspirin increases major bleeding risk (RR 1.80) without reducing ischemic events in primary prevention 1. The combination therapy group experienced 5.74 major bleeds per 100 patient-years versus 1.37 with DOAC monotherapy alone 1.

Plan

1. Pain Management

Prioritize adequate analgesia as pain from ear conditions can be severe 3:

• First-line: Acetaminophen or NSAIDs (ibuprofen)
  • CRITICAL CAVEAT: NSAIDs are associated with dramatically increased bleeding risk (HR 10.25) in patients on apixaban 2
  • Recommendation: Use acetaminophen as first-line analgesic; avoid NSAIDs if possible
• Consider opioid combination (acetaminophen/oxycodone) for severe pain
• Administer at scheduled intervals rather than PRN for better pain control 3

2. Diagnostic Approach

• Otoscopic examination to rule out acute otitis externa (AOE) or acute otitis media
• If AOE is present, assess for modifying factors 3:
  • Non-intact tympanic membrane or tympanostomy tube
  • Diabetes mellitus
  • Immunocompromised state
  • Prior radiotherapy
  • Extension beyond ear canal

3. Treatment Based on Diagnosis

If Acute Otitis Externa IS Present (despite question stating "without infection"):

• Topical therapy is first-line for uncomplicated AOE 4, 3
• Avoid systemic antimicrobials unless extension beyond ear canal or specific host factors present 4, 3
• If tympanic membrane integrity uncertain, use non-ototoxic topical preparation 3
• Perform aural toilet if canal obstructed; consider wick placement 3
• Reassess in 48-72 hours if no improvement 3

If Non-Infectious Cause:

• Cerumen removal if impacted
• Avoid ear canal manipulation
• Address underlying dermatologic condition if present
• Refer to ENT if TMJ dysfunction or other structural issues suspected

4. Anticoagulation Management

CRITICAL RECOMMENDATION: Strongly consider deprescribing aspirin in this patient 1:

• The combination of apixaban plus aspirin for primary prevention significantly increases bleeding risk without reducing ischemic events 1
• Major bleeding incidence: 5.74 vs 1.37 per 100 patient-years (combination vs. monotherapy) 1
• Gastrointestinal bleeding specifically increased with apixaban (HR 2.23) 2
• Contact the prescribing cardiologist to discuss discontinuing aspirin unless there is documented secondary prevention indication (prior MI, stroke, or coronary stenting)

If procedural intervention needed (aural toilet, wick placement):

• These are low-risk bleeding procedures - continue anticoagulation 5
• Apixaban does NOT require bridging or interruption for minor procedures 5
• Apply local hemostatic measures if needed
• Monitor closely for bleeding given dual therapy

5. Patient Education

• Avoid water exposure until resolved
• Do not insert objects into ear canal
• Take analgesics as scheduled, not PRN
• Return immediately if: fever develops, severe headache, neurological symptoms, facial weakness, or significant bleeding
• Discuss bleeding precautions given anticoagulation status 5

6. Follow-Up

• Reassess in 48-72 hours if symptoms persist or worsen
• Coordinate with cardiology regarding aspirin continuation
• Consider ENT referral if refractory or atypical presentation

Key Pitfall to Avoid: Do not prescribe NSAIDs for pain management in this patient on dual antiplatelet/anticoagulant therapy due to dramatically increased bleeding risk (HR 10.25) 2.